Justin J. Wilkins
Amstelveen, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Quantifying Risk of Delayed QT Prolongation of Ipatasertib in Preclinical and Clinical Studies in Cancer Patients.
Journal: Clinical and translational science
Published: February 20, 2025
Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma.
Journal: Clinical and translational science
Published: December 20, 2024
Interplay between pharmacokinetics and immunogenicity of therapeutic proteins: stepwise development of a bidirectional joint pharmacokinetics-anti-drug antibodies model.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: December 06, 2024
A Novel Step-Up Dosage Regimen for Enhancing the Benefit-to-Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.
Journal: Clinical pharmacology and therapeutics
Published: June 03, 2024
Semi-mechanistic population pharmacokinetic/pharmacodynamic modeling of a Plasmodium elongation factor 2 inhibitor cabamiquine for prevention and cure of malaria.
Journal: Antimicrobial agents and chemotherapy
Published: November 15, 2023
Correction to: Training the next generation of pharmacometric modelers: a multisector perspective.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: September 05, 2023
Covariate modeling in pharmacometrics: General points for consideration.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 18, 2023
Training the next generation of pharmacometric modelers: a multisector perspective.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: April 13, 2023
Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection: a randomised, double-blind, placebo-controlled study in the Netherlands.
Journal: The Lancet. Infectious diseases
Published: November 16, 2022
Characterization of exposure-response relationships of ipatasertib in patients with metastatic castration-resistant prostate cancer in the IPATential150 study.
Journal: Cancer chemotherapy and pharmacology
Published: July 14, 2022
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1.
Journal: Cancer chemotherapy and pharmacology
Published: April 05, 2022
Pharmacometrics in tuberculosis: progress and opportunities.
Journal: International journal of antimicrobial agents
Published: March 03, 2022
Last Updated: 09/26/2026